BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 16165296)

  • 21. Promising pharmacogenetic targets for treating alcohol use disorder: evidence from preclinical models.
    Rinker JA; Mulholland PJ
    Pharmacogenomics; 2017 Apr; 18(6):555-570. PubMed ID: 28346058
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Striatal dopamine neurotransmission: regulation of release and uptake.
    Sulzer D; Cragg SJ; Rice ME
    Basal Ganglia; 2016 Aug; 6(3):123-148. PubMed ID: 27141430
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The pharmacology of neurokinin receptors in addiction: prospects for therapy.
    Sandweiss AJ; Vanderah TW
    Subst Abuse Rehabil; 2015; 6():93-102. PubMed ID: 26379454
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Substance P Weights Striatal Dopamine Transmission Differently within the Striosome-Matrix Axis.
    Brimblecombe KR; Cragg SJ
    J Neurosci; 2015 Jun; 35(24):9017-23. PubMed ID: 26085627
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gut-brain peptides in corticostriatal-limbic circuitry and alcohol use disorders.
    Vadnie CA; Park JH; Abdel Gawad N; Ho AM; Hinton DJ; Choi DS
    Front Neurosci; 2014; 8():288. PubMed ID: 25278825
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cannabinoid-1 receptor gene deletion has a compartment-specific affect on the dendritic and axonal availability of μ-opioid receptors and on dopamine axons in the mouse nucleus accumbens.
    Lane DA; Chan J; Lupica CR; Pickel VM
    Synapse; 2010 Dec; 64(12):886-97. PubMed ID: 20939059
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Substance P inhibits GABAB receptor signalling in the ventral tegmental area.
    Xia YF; Margolis EB; Hjelmstad GO
    J Physiol; 2010 May; 588(Pt 9):1541-9. PubMed ID: 20231139
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chronic intermittent hypoxia reduces neurokinin-1 (NK(1)) receptor density in small dendrites of non-catecholaminergic neurons in mouse nucleus tractus solitarius.
    Lessard A; Coleman CG; Pickel VM
    Exp Neurol; 2010 Jun; 223(2):634-44. PubMed ID: 20206166
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Subcellular plasticity of the corticotropin-releasing factor receptor in dendrites of the mouse bed nucleus of the stria terminalis following chronic opiate exposure.
    Jaferi A; Lane DA; Pickel VM
    Neuroscience; 2009 Sep; 163(1):143-54. PubMed ID: 19539724
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The neurokinin-3 (NK3) and the neurokinin-1 (NK1) receptors are differentially targeted to mesocortical and mesolimbic projection neurons and to neuronal nuclei in the rat ventral tegmental area.
    Lessard A; Savard M; Gobeil F; Pierce JP; Pickel VM
    Synapse; 2009 Jun; 63(6):484-501. PubMed ID: 19224600
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Region-specific changes in the subcellular distribution of AMPA receptor GluR1 subunit in the rat ventral tegmental area after acute or chronic morphine administration.
    Lane DA; Lessard AA; Chan J; Colago EE; Zhou Y; Schlussman SD; Kreek MJ; Pickel VM
    J Neurosci; 2008 Sep; 28(39):9670-81. PubMed ID: 18815253
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preferential relocation of the N-methyl-D-aspartate receptor NR1 subunit in nucleus accumbens neurons that contain dopamine D1 receptors in rats showing an apomorphine-induced sensorimotor gating deficit.
    Hara Y; Pickel VM
    Neuroscience; 2008 Jun; 154(3):965-77. PubMed ID: 18479834
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dendritic distributions of dopamine D1 receptors in the rat nucleus accumbens are synergistically affected by startle-evoking auditory stimulation and apomorphine.
    Hara Y; Pickel VM
    Neuroscience; 2007 Jun; 146(4):1593-605. PubMed ID: 17490822
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Psychotic symptoms in a case of locked-in syndrome].
    Mutschler J; Czell D; Kaps M; Manzl G
    Nervenarzt; 2006 Dec; 77(12):1483-6. PubMed ID: 17106731
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Subcellular distribution and plasticity of neurokinin-1 receptors in the rat substantia nigra and ventral tegmental area.
    Lessard A; Pickel VM
    Neuroscience; 2005; 135(4):1309-23. PubMed ID: 16165296
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predominant surface distribution of neurokinin-3 receptors in non-dopaminergic dendrites in the rat substantia nigra and ventral tegmental area.
    Lessard A; Grady EF; Bunnett NW; Pickel VM
    Neuroscience; 2007 Feb; 144(4):1393-408. PubMed ID: 17197098
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Apomorphine-evoked redistribution of neurokinin-3 receptors in dopaminergic dendrites and neuronal nuclei of the rat ventral tegmental area.
    Misono K; Lessard A
    Neuroscience; 2012 Feb; 203():27-38. PubMed ID: 22200547
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neurokinin-1 receptors in cholinergic neurons of the rat ventral pallidum have a predominantly dendritic distribution that is affected by apomorphine when combined with startle-evoking auditory stimulation.
    Mengual E; Chan J; Lane D; San Luciano Palenzuela M; Hara Y; Lessard A; Pickel VM
    Neuroscience; 2008 Feb; 151(3):711-24. PubMed ID: 18178320
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The somatodendritic release of dopamine in the ventral tegmental area and its regulation by afferent transmitter systems.
    Adell A; Artigas F
    Neurosci Biobehav Rev; 2004 Jul; 28(4):415-31. PubMed ID: 15289006
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.